samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > mes gets you to market quicker
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES Gets You to Market Quicker

Probably the biggest single driver for any manufacturer in the pharmaceutical industry has to be the time it takes to get a potential product through the research and development phases and out to market.

With R&D costs to bring a new drug to release approximated at $1 million a day, only when a product is in daily use does the huge investment undertaken by drug companies seeking the next blockbuster product begin to pay back.

There are plenty of examples, across many industries, of companies being late to market with a product, only to find further down the line that competitors’ products have subsequently appeared, with a resulting substantial hit in potential operating profits. Once a company is in the process of research...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Mark Perry has held a number of senior positions, including Sales Director for ABB Process Instrumentation & Micro Control Systems and General Manager for Rockwell Automation EMEA Asset Management. He joined Siemens in 2003 as General Sales Manager for the Process Instrumentation Group before moving into the automation and drives process sector, heading up teams focusing on the chemical/pharmaceutical, food and beverage and oil and gas sectors. In 2007, Mark took up the position as Business Manager for the Siemens UK MES group, with responsibility for, among others, the pharmaceutical industry.
spacer
Mark Perry
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vetter further expands its Development Service with new site in Austria

CDMO addressing growing customer demand Investment in additional clinical filling options in Europe Planned ‘go live’ in 2021 Ravensburg, Germany and Rankweil, Austria, July 8, 2020 – With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
More info >>

White Papers

Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods

Sepha Limited

A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement